Understanding how a specific protein affects insulin production in adult human pancreatic cells
Molecular mechanisms of NKX2.2 function in adult human beta cells
This study is looking at how a protein called NKX2.2 affects insulin production in the cells that help control blood sugar, which is important for people with type 2 diabetes, to find out more about how diabetes works and possibly discover new treatments.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11000806 on NIH RePORTER |
What this research studies
This research investigates the role of the NKX2.2 protein in regulating insulin secretion from adult human pancreatic beta cells, which are crucial for maintaining blood sugar levels. By using advanced techniques like CRISPR/Cas9 to modify these cells, the researchers aim to uncover how NKX2.2 influences beta cell function and contributes to the development of type 2 diabetes. The study will involve analyzing changes in cell signaling and function in specially prepared human cell models. This could lead to a better understanding of diabetes mechanisms and potential new treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with type 2 diabetes or those at risk of developing the condition.
Not a fit: Patients with type 1 diabetes or those without any form of diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for type 2 diabetes by enhancing our understanding of insulin regulation.
How similar studies have performed: Previous research has shown promising results in understanding beta cell function through similar molecular approaches, indicating potential for success in this area.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Pettway, Yasminye D — Vanderbilt University
- Study coordinator: Pettway, Yasminye D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.